BRPI0606614A2 - peptìdeos para distribuição de vacinas na mucosa - Google Patents

peptìdeos para distribuição de vacinas na mucosa

Info

Publication number
BRPI0606614A2
BRPI0606614A2 BRPI0606614-3A BRPI0606614A BRPI0606614A2 BR PI0606614 A2 BRPI0606614 A2 BR PI0606614A2 BR PI0606614 A BRPI0606614 A BR PI0606614A BR PI0606614 A2 BRPI0606614 A2 BR PI0606614A2
Authority
BR
Brazil
Prior art keywords
peptides
vaccine delivery
mucosal vaccine
peptide
antigen
Prior art date
Application number
BRPI0606614-3A
Other languages
English (en)
Inventor
Magistris Maria Teresa De
Alessio Fasano
Original Assignee
Univ Maryland
Inst Superiore Di Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland, Inst Superiore Di Sanita filed Critical Univ Maryland
Publication of BRPI0606614A2 publication Critical patent/BRPI0606614A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

PEPTìDEOS PARA DISTRIBUIçãO DE VACINAS NA MUCOSA. A presente invenção se refere a um peptídeo adjuvante e a usos para facilitar a absorção de antígeno na mucosa, particularmente tecido nasal. As composições de vacina para distribuição na mucosa incluem o peptídeo adjuvante e um antígeno para indizir uma resposta imune.
BRPI0606614-3A 2005-01-14 2006-01-13 peptìdeos para distribuição de vacinas na mucosa BRPI0606614A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64360605P 2005-01-14 2005-01-14
PCT/US2006/001254 WO2006076587A2 (en) 2005-01-14 2006-01-13 Peptides for delivery of mucosal vaccines

Publications (1)

Publication Number Publication Date
BRPI0606614A2 true BRPI0606614A2 (pt) 2009-07-07

Family

ID=36678231

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606614-3A BRPI0606614A2 (pt) 2005-01-14 2006-01-13 peptìdeos para distribuição de vacinas na mucosa

Country Status (13)

Country Link
US (1) US20060165722A1 (pt)
EP (1) EP1841451A4 (pt)
JP (1) JP2008526985A (pt)
KR (1) KR20070117551A (pt)
CN (1) CN101115503A (pt)
AR (1) AR053661A1 (pt)
AU (1) AU2006204784A1 (pt)
BR (1) BRPI0606614A2 (pt)
CA (1) CA2594911A1 (pt)
IL (1) IL184609A0 (pt)
RU (1) RU2007130148A (pt)
TW (1) TW200637573A (pt)
WO (1) WO2006076587A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019412A2 (en) 2003-05-20 2005-03-03 New York University Mucosal immunization to prevent prion infection
US8685718B2 (en) 2003-05-20 2014-04-01 New York University Mucosal immunization to prevent prion infection
FR2864882B1 (fr) * 2004-01-13 2006-05-26 Christophe Rovida Chaussure a semelle interchangeable
WO2008154350A2 (en) * 2007-06-08 2008-12-18 Alba Therapeutics Corporation Use of tight junction agonists to suppress immune responses
WO2010128016A2 (en) * 2009-05-04 2010-11-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Par2 agonists for use in the treatment or prevention of influenza virus type a infections
EP3440096A4 (en) * 2016-04-06 2019-11-13 Ewha University-Industry Collaboration Foundation PEPTIDE WITH ABILITY TO CELL MEMBRANE PENETRATION
CN111670040A (zh) * 2018-01-08 2020-09-15 密歇根大学董事会 Aldh1抗原冲击树突状细胞
WO2020091535A1 (ko) * 2018-11-02 2020-05-07 순천향대학교 산학협력단 점막 투과 촉진용 펩타이드 및 이를 포함하는 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) * 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5827534A (en) * 1995-05-24 1998-10-27 University Of Maryland At Baltimore Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes
US5908825A (en) * 1997-01-09 1999-06-01 University Of Maryland At Baltimore Dosage composition for nasal delivery and method of use of the same
US5864014A (en) * 1997-02-20 1999-01-26 University Of Maryland At Baltimore Zonula occludens toxin receptor
US5912323A (en) * 1997-02-20 1999-06-15 University Of Maryland, Baltimore Zonula occludens toxin receptors
US5945510A (en) * 1997-05-21 1999-08-31 University Of Maryland, Baltimore Substantially pure zonulin, a physiological modulator of mammalian tight junctions
US6610392B1 (en) * 1998-03-04 2003-08-26 Cryovac, Inc. Heat-shrinkable multilayer packaging film comprising inner layer comprising a polyester
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
US6558670B1 (en) * 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
US7132109B1 (en) * 2000-10-20 2006-11-07 University Of Connecticut Health Center Using heat shock proteins to increase immune response
DE60314495T2 (de) * 2002-02-07 2008-03-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Aminosäuresequenzen, die in der lage sind die durchdringung einer biologischen barriere zu erleichtern
BR0303362A (pt) * 2002-03-06 2005-07-19 Univ Arizona State Composição e método para melhorar uma resposta imune em um animal, método para distribuir uma proteìna de carga em uma célula de animal, célula viva geneticamente modificada, e, método para a construção de uma proteìna de fusão para melhorar a resposta imune em um animal
EP1648917A4 (en) * 2003-07-15 2008-11-12 Univ Maryland AGONISTPOLYPEPTIDE OF THE RECEPTOR FOR ZOT AND ZONULIN

Also Published As

Publication number Publication date
KR20070117551A (ko) 2007-12-12
US20060165722A1 (en) 2006-07-27
RU2007130148A (ru) 2009-02-20
EP1841451A2 (en) 2007-10-10
CA2594911A1 (en) 2006-07-20
CN101115503A (zh) 2008-01-30
AR053661A1 (es) 2007-05-16
IL184609A0 (en) 2007-12-03
TW200637573A (en) 2006-11-01
EP1841451A4 (en) 2008-11-05
JP2008526985A (ja) 2008-07-24
WO2006076587A2 (en) 2006-07-20
WO2006076587A3 (en) 2007-02-01
AU2006204784A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
BRPI0606614A2 (pt) peptìdeos para distribuição de vacinas na mucosa
CY1119265T1 (el) Κατασκευες νανοσωματων τρισθενους αντι ανθρωπινου αναπνευστικου συγκυτιακου ιου (hrsv) για την προληψη και/ή θεραπεια λοιμωξεων της αναπνευστικης οδου
DE122011100053I1 (de) Influenza vakzinzusammensetzungen zur intradermaler verabreichung.
CO6491045A2 (es) Composiciones de proteina f de virus sincitial respiratorio (rsv) y metodos para producir las mismas
PE20121393A1 (es) Analogo peptidico de oxintomodulina
BRPI0510430A (pt) composições e métodos para vacinação mucosal
EP3533461A3 (en) Prame derived peptides and immunogenic compositions comprising these
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
CO5700790A2 (es) Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina
WO2010037027A3 (en) Immunization of avians by mucosal administration of non-replicating vectored vaccines
CO6561830A2 (es) Vacuna de péptido ch3 de ige
BRPI0707779B8 (pt) antígeno isolado, composição de vacina e método para produção de uma proteína antígeno
ES2585328T3 (es) Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
CR11307A (es) Vacunas
WO2008054535A3 (en) Novel influenza m2 vaccines
WO2007098718A8 (es) Antígenos vacunales quiméricos contra el virus de la influenza aviar
NZ594268A (en) Grass peptides for vaccine
EA201690115A1 (ru) Комбинированные иммуногенные композиции
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
WO2011017442A3 (en) Anti-rsv immunogens and methods of immunization
CR11537A (es) Vacuna
WO2008028667A3 (en) Use of glycolipids as adjuvants
NZ593200A (en) Peptide adjuvants
BR112014001287A2 (pt) vacina recombinante do vírus da leucemia felina contendo gene otimizado do envelope do vírus da leucemia felina
BRPI0517745A (pt) vìrus mutante da sìndrome reprodutiva e respiratória de suìnos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.